BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Maula Bux on June 19, 2014 and is headquartered in Richmond, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company